Secretion of N-terminal fragment of γ-human atrial natriuretic polypeptide

Hiroshi Itoh, Kazuwa Nakao, Masashi Mukoyama, Akira Sugawara, Yoshihiko Saito, Narito Morii, Takayuki Yamada, Shozo Shiono, Hiroshi Arai, Hiroo Imura

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

To elucidate the posttranslational processing of γ-human atrial natriuretic polypeptide (human atrial natriuretic factor-[1-126]), which is a prohormone of α-human atrial natriuretic polypeptide (human atrial natriuretic factor-[99-126]), and the secretion of γ-human atrial natriuretic polypeptide-derived peptides from the heart, we established a radioimmunoassay specific for the N-terminal sequence of γ-human atrial natriuretic polypeptide, γ-human atrial natriuretic polypeptide-(1-25), as well as a radioimmunoassay for α-human atrial natriuretic polypeptide. With the aid of the radioimmunoassays for γ-human atrial natriuretic polypeptide-(1-25) and for γ-human atrial natriuretic polypeptide, we detected 290 ± 35.6 pg/ml of γ-human atrial natriuretic polypeptide-(1-25 Hike immunoreactivity in plasma from healthy humans, while the simultaneously determined plasma α-human atrial natriuretic polypeptide-like immunoreactivity level was 20.9 ± 2.8 pg/ml. Correlation between the two values was significant. High performance gel permeation chromatographic analysis revealed that the plasma γ-human atrial natriuretic polypeptide-(1-25)-like Immunoreactivity was composed of a component (molecular weight, 10,000) without α-human atrial natriuretic polypeptide-like immunoreactivity, while the plasma γ-human atrial natriuretic polypeptide-like immunoreactivity was composed of α-human atrial natriuretic polypeptide with a molecular weight of 3000. In patients with heart diseases, the plasma γ-human atrial natriuretic polypeptide-(1-25)-like immunoreactivity level showed a concomitant and graded increase, with the plasma α-human atrial natriuretic polypeptide-like unmunoreactivity level in agreement with the severity of the disease. There were significant positive correlations between the two immunoreactivity levels and right or left atrial pressure. These results suggest cosecretion of 10 K N-terminal fragment of γ-human atrial natriuretic polypeptide and α-human atrial natriuretic polypeptide into the circulation in response to increased atrial stretch.

Original languageEnglish
Pages (from-to)I-52-I-56
JournalHypertension
Volume11
Issue number2
Publication statusPublished - 1988
Externally publishedYes

Fingerprint

Peptides
Radioimmunoassay
Atrial Natriuretic Factor
Molecular Weight
Atrial Pressure
Gel Chromatography
Heart Diseases

Keywords

  • Atrial natriuretic factor
  • Atrial pressure
  • Congestive heart failure
  • Posttranslational processing
  • Prohormone
  • Radioimmunoassay

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Itoh, H., Nakao, K., Mukoyama, M., Sugawara, A., Saito, Y., Morii, N., ... Imura, H. (1988). Secretion of N-terminal fragment of γ-human atrial natriuretic polypeptide. Hypertension, 11(2), I-52-I-56.

Secretion of N-terminal fragment of γ-human atrial natriuretic polypeptide. / Itoh, Hiroshi; Nakao, Kazuwa; Mukoyama, Masashi; Sugawara, Akira; Saito, Yoshihiko; Morii, Narito; Yamada, Takayuki; Shiono, Shozo; Arai, Hiroshi; Imura, Hiroo.

In: Hypertension, Vol. 11, No. 2, 1988, p. I-52-I-56.

Research output: Contribution to journalArticle

Itoh, H, Nakao, K, Mukoyama, M, Sugawara, A, Saito, Y, Morii, N, Yamada, T, Shiono, S, Arai, H & Imura, H 1988, 'Secretion of N-terminal fragment of γ-human atrial natriuretic polypeptide', Hypertension, vol. 11, no. 2, pp. I-52-I-56.
Itoh H, Nakao K, Mukoyama M, Sugawara A, Saito Y, Morii N et al. Secretion of N-terminal fragment of γ-human atrial natriuretic polypeptide. Hypertension. 1988;11(2):I-52-I-56.
Itoh, Hiroshi ; Nakao, Kazuwa ; Mukoyama, Masashi ; Sugawara, Akira ; Saito, Yoshihiko ; Morii, Narito ; Yamada, Takayuki ; Shiono, Shozo ; Arai, Hiroshi ; Imura, Hiroo. / Secretion of N-terminal fragment of γ-human atrial natriuretic polypeptide. In: Hypertension. 1988 ; Vol. 11, No. 2. pp. I-52-I-56.
@article{ac9a2d90d9484f63be9092353f85cc95,
title = "Secretion of N-terminal fragment of γ-human atrial natriuretic polypeptide",
abstract = "To elucidate the posttranslational processing of γ-human atrial natriuretic polypeptide (human atrial natriuretic factor-[1-126]), which is a prohormone of α-human atrial natriuretic polypeptide (human atrial natriuretic factor-[99-126]), and the secretion of γ-human atrial natriuretic polypeptide-derived peptides from the heart, we established a radioimmunoassay specific for the N-terminal sequence of γ-human atrial natriuretic polypeptide, γ-human atrial natriuretic polypeptide-(1-25), as well as a radioimmunoassay for α-human atrial natriuretic polypeptide. With the aid of the radioimmunoassays for γ-human atrial natriuretic polypeptide-(1-25) and for γ-human atrial natriuretic polypeptide, we detected 290 ± 35.6 pg/ml of γ-human atrial natriuretic polypeptide-(1-25 Hike immunoreactivity in plasma from healthy humans, while the simultaneously determined plasma α-human atrial natriuretic polypeptide-like immunoreactivity level was 20.9 ± 2.8 pg/ml. Correlation between the two values was significant. High performance gel permeation chromatographic analysis revealed that the plasma γ-human atrial natriuretic polypeptide-(1-25)-like Immunoreactivity was composed of a component (molecular weight, 10,000) without α-human atrial natriuretic polypeptide-like immunoreactivity, while the plasma γ-human atrial natriuretic polypeptide-like immunoreactivity was composed of α-human atrial natriuretic polypeptide with a molecular weight of 3000. In patients with heart diseases, the plasma γ-human atrial natriuretic polypeptide-(1-25)-like immunoreactivity level showed a concomitant and graded increase, with the plasma α-human atrial natriuretic polypeptide-like unmunoreactivity level in agreement with the severity of the disease. There were significant positive correlations between the two immunoreactivity levels and right or left atrial pressure. These results suggest cosecretion of 10 K N-terminal fragment of γ-human atrial natriuretic polypeptide and α-human atrial natriuretic polypeptide into the circulation in response to increased atrial stretch.",
keywords = "Atrial natriuretic factor, Atrial pressure, Congestive heart failure, Posttranslational processing, Prohormone, Radioimmunoassay",
author = "Hiroshi Itoh and Kazuwa Nakao and Masashi Mukoyama and Akira Sugawara and Yoshihiko Saito and Narito Morii and Takayuki Yamada and Shozo Shiono and Hiroshi Arai and Hiroo Imura",
year = "1988",
language = "English",
volume = "11",
pages = "I--52--I--56",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Secretion of N-terminal fragment of γ-human atrial natriuretic polypeptide

AU - Itoh, Hiroshi

AU - Nakao, Kazuwa

AU - Mukoyama, Masashi

AU - Sugawara, Akira

AU - Saito, Yoshihiko

AU - Morii, Narito

AU - Yamada, Takayuki

AU - Shiono, Shozo

AU - Arai, Hiroshi

AU - Imura, Hiroo

PY - 1988

Y1 - 1988

N2 - To elucidate the posttranslational processing of γ-human atrial natriuretic polypeptide (human atrial natriuretic factor-[1-126]), which is a prohormone of α-human atrial natriuretic polypeptide (human atrial natriuretic factor-[99-126]), and the secretion of γ-human atrial natriuretic polypeptide-derived peptides from the heart, we established a radioimmunoassay specific for the N-terminal sequence of γ-human atrial natriuretic polypeptide, γ-human atrial natriuretic polypeptide-(1-25), as well as a radioimmunoassay for α-human atrial natriuretic polypeptide. With the aid of the radioimmunoassays for γ-human atrial natriuretic polypeptide-(1-25) and for γ-human atrial natriuretic polypeptide, we detected 290 ± 35.6 pg/ml of γ-human atrial natriuretic polypeptide-(1-25 Hike immunoreactivity in plasma from healthy humans, while the simultaneously determined plasma α-human atrial natriuretic polypeptide-like immunoreactivity level was 20.9 ± 2.8 pg/ml. Correlation between the two values was significant. High performance gel permeation chromatographic analysis revealed that the plasma γ-human atrial natriuretic polypeptide-(1-25)-like Immunoreactivity was composed of a component (molecular weight, 10,000) without α-human atrial natriuretic polypeptide-like immunoreactivity, while the plasma γ-human atrial natriuretic polypeptide-like immunoreactivity was composed of α-human atrial natriuretic polypeptide with a molecular weight of 3000. In patients with heart diseases, the plasma γ-human atrial natriuretic polypeptide-(1-25)-like immunoreactivity level showed a concomitant and graded increase, with the plasma α-human atrial natriuretic polypeptide-like unmunoreactivity level in agreement with the severity of the disease. There were significant positive correlations between the two immunoreactivity levels and right or left atrial pressure. These results suggest cosecretion of 10 K N-terminal fragment of γ-human atrial natriuretic polypeptide and α-human atrial natriuretic polypeptide into the circulation in response to increased atrial stretch.

AB - To elucidate the posttranslational processing of γ-human atrial natriuretic polypeptide (human atrial natriuretic factor-[1-126]), which is a prohormone of α-human atrial natriuretic polypeptide (human atrial natriuretic factor-[99-126]), and the secretion of γ-human atrial natriuretic polypeptide-derived peptides from the heart, we established a radioimmunoassay specific for the N-terminal sequence of γ-human atrial natriuretic polypeptide, γ-human atrial natriuretic polypeptide-(1-25), as well as a radioimmunoassay for α-human atrial natriuretic polypeptide. With the aid of the radioimmunoassays for γ-human atrial natriuretic polypeptide-(1-25) and for γ-human atrial natriuretic polypeptide, we detected 290 ± 35.6 pg/ml of γ-human atrial natriuretic polypeptide-(1-25 Hike immunoreactivity in plasma from healthy humans, while the simultaneously determined plasma α-human atrial natriuretic polypeptide-like immunoreactivity level was 20.9 ± 2.8 pg/ml. Correlation between the two values was significant. High performance gel permeation chromatographic analysis revealed that the plasma γ-human atrial natriuretic polypeptide-(1-25)-like Immunoreactivity was composed of a component (molecular weight, 10,000) without α-human atrial natriuretic polypeptide-like immunoreactivity, while the plasma γ-human atrial natriuretic polypeptide-like immunoreactivity was composed of α-human atrial natriuretic polypeptide with a molecular weight of 3000. In patients with heart diseases, the plasma γ-human atrial natriuretic polypeptide-(1-25)-like immunoreactivity level showed a concomitant and graded increase, with the plasma α-human atrial natriuretic polypeptide-like unmunoreactivity level in agreement with the severity of the disease. There were significant positive correlations between the two immunoreactivity levels and right or left atrial pressure. These results suggest cosecretion of 10 K N-terminal fragment of γ-human atrial natriuretic polypeptide and α-human atrial natriuretic polypeptide into the circulation in response to increased atrial stretch.

KW - Atrial natriuretic factor

KW - Atrial pressure

KW - Congestive heart failure

KW - Posttranslational processing

KW - Prohormone

KW - Radioimmunoassay

UR - http://www.scopus.com/inward/record.url?scp=0023919404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023919404&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - I-52-I-56

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -